Narcotic Analgesics and Anesthesia Drugs Narcotic Analgesics.
Addressing the pharmaceutical problem in hospital...
Transcript of Addressing the pharmaceutical problem in hospital...
27/05/2016
1
Addressing the pharmaceutical problem in hospital wastewater
Maja Zupančič Justin, Arhel d.o.o.
LIFE Water Platform Meeting24th- 25th May, 2016, Manchester, UK
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
« LIFE PharmDegrade »
- Demonstration of technology for removal of PH from the wastewater effluents
- Electrochemical oxidation in electrolytic cell - Diamond electrodes
Degradation of pharmaceuticals (PH) in wastewaters from nursing homes and hospitals
27/05/2016
2
Specifics of hospital wastewater
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
- Specific contaminants - micro pollutants / emerging pollutants:- Pharmaceutical (e.g. laxatives, analgesics, anti-inflammatory, antibiotics, cytostatic)- Disinfectants- Detergents (personal care, laundry, washing)
- X-ray contrast media, other diagnostic agents- Microbiological load (multi-resistant microbes)
- Organic load with potential low biodegradability (BOD5/COD range)- pH shocks (disinfection)- Seasonal/daily/regional variation of effluent composition (seasonal diseases)
*P. Verlicchi, M. Al Aukidy, E. Zambello, 2015, What have we learned from worldwide experiences on the management and treatment of hospital effluent? An overview and a discussion on perspectives, Science of the total Environment
Main chemical characteristics of hospital effluent*
Impact of PH in wastewater on the environment
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
Environmental concern:• Persistence in the environment:
• High polarity of substances:• Easy discharge from the body• Resistant to biological degradation in treatment plant
• Development of antibiotic resistant microorganisms; antibiotic resistant genes• Toxicity to aquatic organisms – (ciprofloxacin - algal growth inhibition; diclofenac -
alters the kidney functions in fishes and birds; cytostatics - genotoxicity)• Endocrine disruptors – affect the reproduction of organisms• Bioaccumulation
Difficulties in municipal wastewater treatment plants:- pH shocks, toxicity inhibitor / disintegration of activated sludge low
treatment efficiency- Low biodegradability reduction of removal efficiency
Presence in drinking water, irrigation water
27/05/2016
3
Commonly adopted hospital wastewater treatment
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
Outflow to municipal sewage system
Treatment: Preliminary treatment, (primary clarification) Secondary biological treatment (conventional activated sludge process) Polishing treatments (chemical disinfection / rapid filtration + UV disinfection)
• Is treatment in municipal wastewater treatment plant (WWTP) adequate to reach high removal efficiencies for wide spectrum of micro pollutants ?
• Is load of PH from hospitals significant compared to total urban load?
• Should dedicated treatment be adopted for hospital WW?
• Which kind of WWT would be appropriate?
• Is the risk of PH residuals in the environment appropriately addressed?
Households Sewage
?
?
?
Do hospitals contribute a significant amount of PH to urban load?
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
*Daouk et al., 2016: Dynamics of active pharmaceutical ingredients loads in a Swiss university hospital wastewaters and prediction of the related environmental risk for the aquatic ecosystems. Sci. Tot. Env.
Swiss University hospital case*:- 15 PH analysed:
• Only consumed in hospital: piperacilin, cisplatin, gadopentetic acid • Relatively important contribution from hospital: codeine, morphine, metronidazole,
sulfamethoxazole• Mainly consumed in households: mefenamic acid, diclofenac, carbamazepine, ..
- all PH participate to the environmental hazard (HQ > 1),
- Risk for the aquatic environment after dilution in urban network, receiving water body and WWTP (activated sludge):
- Hospital load:- Ciprofloxacin high (RQ>1)- Sulfamethoxazole moderate (1>RQ>0,1)- API mixture toxicity >1
- Total urban load:- gabapentin, sulfamethoxazole, ciprofloxacin, piperacillin, ibuprofen, diclofenac, mefenamicacid (RQ > 1)
- On-site advanced treatment proposed- Municipal WWT should be improved
27/05/2016
4
Do hospitals contribute a significant amount of PHtourban load? (cont.)
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
Portuguese case*:
Santos et al., 2013: Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: Identification of ecologically relevant pharmaceuticals. Sci. Tot. Env.
- 78 PHs considered- PH widespread pollutants in hospital and public WW- Hospital WW contained higher PH concentrations- Public WWTP effluent contribute the higher mas load of PH - Therapeutic groups with highest input from hospitals: NSAID, analgesics, antibiotics- Therapeutic groups with highest input from public WW: antihypertensive, psychiatric drugs, lipid regulators- 90% removal efficiency (activated sludge):
- Acetaminophen- Ibuprofen
- No removal fficiency:- Beta-blockers- antihelmintics- Sulbutamol
- Antibiotics (ciprofloxacin, ofloxacin, sulfamethoxazole, azithromycin, clarithromycin) pose ecotoxicological risk to algae –special attention needed
- Need to assess ecotoxicity of mixture of PHs- Co-treatment of hospital and public WW should be improved
Pharmaceuticals: legislative backgroundA Blueprint to Safeguard Europe`s Water Resources (COM(2012) 673:
2.2 Chemical status and pollution of EU waters: problems and solutions:- Pharmaceutical residues is an emerging problem- Human and veterinary medicinal products need for:
- Environmental risk assessment- Case-by-case consideration of the need for protective measures
Proposal for directive .. Amending the Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy (COM/2011)876)
- 3 pharmaceuticals proposed on the list:
Directive 2013/39/EU amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy
- Pharmaceuticals not on the list The First Watch list created (JRC)
27/05/2016
5
Pharmaceuticals: legislative background (cont.)
Development of the first Watch List under the Environmental Quality Standards Directive (JRC, 2015)
- Watch list of compounds which need further monitoring before listing to Env. Quality Standard Directive- It will contain 10 compounds; 3 already listed:
- Diclofenac*; - 17-beta-esrtadiol (E2)**; - 17-alpha-ethnylestradiol (EE2)**
- Candidate compounds (7 will be selected): - trichlorfon, cyclododecane, imidacloprid, diflufenican, oxadiazon, tri-allate, methiocarb, 2,6-di-tert-butyl-4-
methylphenol, thiacloprid, aminotriazole, clothianidin, chromium trioxide, thiamethoxam, 2-ethylhexyl 4-methoxycinnamate, dichlofluanid, formaldehyde, dimethenamid-P, triphenyl phosphate, acetamiprid, ofloxacin***, erythromycin***, clarithromycin***, ciprofloxacin***, tolylfluanid, azithromycin*** and free cyanide
Pharmaceuticals:* anti-inflammatory , analgesic** Estrogenic hormone*** antibioticsOther compounds: UV stabilizer and fuel antioxidant, insecticides, pesticides, sun screen ingredient
Underlined – most recommended for the first Watch List
Adopted Commission Decision 2015/495 – watch list- EE2, E1, diclofenac- Macrolide antibiotics (erythromycin, clarithromycin, azithromycin)
Pharmaceuticals detected in short screening in LIFE PharmDegrade project
MWWTP NH 1 NH 2 NH 3 NH 4 H 2014 H 2015Priority
substance Watch listCandidate
compounds* Initial list*
Critical predicted environmental concentration*
ng/L ng/L ng/L ng/L ng/L ng/L ng/L ng/L
beta blockersbisoprolol 14,3 391,9 164,7 484,4 378,4 134,2 414,10
metoprolol 492,5 371,0 156,9 714,2 87,8 88,8 81,43
anti-epileptic carbamazepine 216,9 18,1 555,1 77,7 345,8 9,6 573,25 x
antibiotic (human, veterinary)
ciprofloxacin772,2 22417,9 38078,0 < LOQ 8154,6 10321,6 3560,65 x x 0,54
cholesterol treatmentclofibric acid < LOQ < LOQ < LOQ < LOQ < LOQ < LOQ
atorvastatin 65,41
anti-inflammatory diclofenac 2244,5 581,9 < LOQ < LOQ 323,3 248,2 3247,50 X
anti-depressantfluoxetine 6,3 < LOQ < LOQ < LOQ < LOQ < LOQ
setraline 61,60
citostatic imatinib < LOQ < LOQ < LOQ < LOQ < LOQ 1,9 7,67
plant protectionatrazine 2,5 < LOQ < LOQ < LOQ 11,5 < LOQ x
simazine < LOQ < LOQ < LOQ < LOQ < LOQ < LOQ x
MWWTP – municipal wastewater treatment plantNH – Nursing HomeH - Hospital
* Development of the first Watch List under the Environmental Quality Standards Directive (JRC, 2015)
- Similar concentrations in municipal sewage and sewage with hospital WW load- Nursing home – lower concentration (incontinence – other disposal routes)
More results on preliminary project activities (analytical metods used, first treatment trials with boron doped electrodes) presented on poster by J. Trontelj on the LIFE Water Platform Meeting:A. Klančar, J. Trontelj et al.: I. Optimisation of LC-MS/MS method for quantification of selected pharmaceuticals in wastewater effluent II. Evaluation of electrolytic cell performance under various conditions
27/05/2016
6
Environmental classification of found pharmaceuticals
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
According to: Environmentally classified pharmaceuticals, 2009; Stockholm Country Council
max conc found* (ng/L) risk TBT P B T
beta blockersbisoprolol 484,4
metoprolol 714,2 insignificant 4 3 0 1
anti-epileptic carbamazepine 573,3 insignificant 4 3 0 1
antibiotic (human, veterinary) ciprofloxacin 38078,0 Can nnot be excl. 5 3 0 2
cholesterol treatmentclofibric acid < LOQ
atorvastatin 65,4 insignificant 4 3 0 1
anti-inflammatory diclofenac 3247,5 insignificant 4 3 0 1
anti-depressantfluoxetine 6,3 low 6 3 0 3
setraline 61,6 moderate 6 3 0 3
citostatic imatinib 7,7 insignificant 5 3 0 2
P = PERSISTENCE: ability to resist biodegradation (0-3)B = BIOACCUMULATION: accumulation in adipose tissue (0 –3)T = TOXICITY: potential to poison aquatic organism (fish, Daphnia, algae) (0 – 3)
BPT index - total of B, P, T (0-9)
PEC = Predicted Environmental ConcentrationPNEC = Predicted No Effect Concentration; the highest
concentration of the substance that does not have harmful effect in the environment
* Max concentration found in PharmDegrade short survey
Are risks higher as indicated?Development of resistance as additional concern?
Ciprofloxacin case
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
- We detected so far 0,038 mg/L in WWTP outflow – toxic level for algae (cyanobacteria)
- Most frequently detected fluoroquinolone antibiotic in hospital WW- 0,164 and 6,5 mg/L median and maximum concentration in water- Not biodegradable (0% degradation over 40 day incubation)- Found concentrations in WW potential environmental concern
Source: Development of the first Watch List under the Environmental Quality Standards Directive (JRC, 2015)
27/05/2016
7
Approaches to reduce pharmaceuticals from wastewater
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
Approaches:
• Activated sludge process• Membrane bioreactors• Treatment wetlands• Chlorination• UV disinfection• Ozonation• Ultrafiltration• Nano filtration• Activated carbon filtration• Advanced oxidation processes:
• Fenton process, electrochemical oxidation, H2O2 + UV• Combination of these
Issues:
Removal/degradation efficiency
Disinfection efficiency
Retention times
Investment & operation costs; land requirement
By-products development (Eco-toxicological effects)
Electrochemical oxidation and diamond electrodes
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
• Boron-doped diamond electrodes (BDD) was used• Formation of HO• radicals directly from water with the use of
electric power• Complete mineralisation of organic compounds or converting them
to more hydrophilic molecules
• very effective degradation observed for ciprofloxacin, imatinib, fluoxetine, sertraline, diclofenac and atorvastatin
• less effective: metoprolol, bisoprolol and clofibric acid
Further work on:• Self cleaning of electrodes• Control of electrode activity• Optimisation of treatment efficiency (contact times, combining
treatment systems)
27/05/2016
8
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
The technology used should not necessarily lead to complete removal of PH but to reduction of ecotoxicological effect
Synergistic toxicity of PH mixtures is often neglected Antibiotics are of a high importance due to ecotoxicity and resistance development
Nursing homes have different PH disposal ways than hospitals and public WW Hospitals important from the point of view of release of:
High concentrations of specific groups of PH Multi-resistant pathogenic microbes
Public WW are important from the high mass load of PH WWT should be improved In areas with WWTP receiving high effluent contribution from hospitals on-site treatment should
be considered
Some conclusions
LIFE13 ENV/SI/000466
http://lifepharmdegrade.arhel.si
L. & T. ROZINA
We expect to provide soon new results from LIFE PharmDegrade project
http://lifepharmdegrade.arhel.si